Moderna has applied to the US Food and Drug Administration (FDA) for a change in the marketing authorization (EUA) of its mRNA vaccine against COVID-19. If the Agency agrees, it will be possible to give a fourth dose of the vaccine to people from 18 years of age who have received a first booster dose of any authorized COVID-19 vaccine.
The applicat...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
